Osteogenic protein-1 protects against cerebral infarction induced by MCA ligation in adult rats

Stroke

Volumn 30, Issue 1, 1999, Pages 126-133

  Lin, Shinn Zong ^a   Hoffer, Barry J ^b   Kaplan, Paul ^c   Wang, Yun ^a,d  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b UNIVERSITY OF COLORADO   (United States)

^c CURIS INC   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Bone morphogenetic proteins; Cerebral infarction; Cerebral ischemia; Neuroprotection; Rats

Indexed keywords

CHLORAL HYDRATE; OSTEOGENIC PROTEIN 1; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRIPHENYLTETRAZOLIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; CONTROLLED STUDY; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032937759     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.1.126     Document Type: Article

References (49)

1. Yonemori K, Imamura T, Ishidou Y, Okano T, Matsunaga S, Yoshida H, Kato M, Sampath TK, Miyazono K, ten Dijke P, Sakou T. Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament. Am J Pathol. 1997;150:1335-1347.
2. Lietman SA, Yanagishita M, Sampath TK, Reddi AH. Stimulation of proteoglycan synthesis in explants of porcine articular cartilage by recombinant osteogenic protein-1 (bone morphogenetic protein-7). J Bone Joint Surg Am. 1997;79:1132-1137.
3. Kitten AM, Lee JC, Olson MS. Osteogenic protein-1 enhances phenotypic expression in ROS 17/2. 8 cells. Am J Physiol. 1995;269:E918-E926.
4. Ripamonti U, Duneas N, VandenHeever B, Bosch C, Crooks J. Recombinant transforming growth factor-beta 1 induces endochondral bone in the baboon and synergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation. J Bone Miner Res. 1997;12:1584-1595.
5. Helder MN, Ozkaynak E, Sampath KT, Luyten FP, Latin V, Oppermann H, Vukicevic S. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J Histochem Cytochem. 1995;43:1035-1044.
6. Dudley AT, Robertson EJ. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn. 1997;208:349-362.
7. Mehler MF, Mabie PC, Zhang DM, Kessler JA. Bone morphogenetic proteins in the nervous system. Trends Neurosci. 1997;20:309-317.
8. Jordan J, Bottner M, Schluesener HJ, Unsicker K, Krieglstein K. Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur J Neurosci. 1997;9: 1699-1709.
9. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA. 1995;92:7632-7636.
10. Harada S, Sampath TK, Aubin JE, Rodan GA. Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence. Mol Endocrinol. 1997;11:1832-1845.
11. Piek E, Franzen P, Heldin CH, ten Dijke P. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding. J Cell Physiol. 1997;173:447-459.
12. Soderstrom S, Bengtsson H, Ebendal T. Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain. Cell Tissue Res. 1996;286:269-279.
13. Liu F, Ventura F, Doody J, Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol. 1995;15:3479-3486.
14. Lewen A, Soderstrom S, Hillered L, Ebendal T. Expression of serine/threonine kinase receptors in traumatic brain injury. Neuroreport. 1997; 8:475-479.
15. Oh SH, Johnson R, Wu DK. Differential expression of bone morphogenetic proteins in the developing vestibular and auditory sensory organs. J Neurosci. 1996;16:6463-6475.
16. Furuta Y, Piston DW, Hogan BL. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development. 1997;124: 2203-2212.
17. Perides G, Jensen FE, Edgecomb P, Rueger DC, Charness ME. Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia. Neurosci Lett. 1995;187:21-24.
18. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 1992;31:100-107.
19. Wang Y, Lin SZ, Chiou AL, Williams LR, Hoffer BJ. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci. 1997;17:4341-4348.
20. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986;17:738-743.
21. Du C, Hu R. Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis. J Cereb Blood Flow Metab. 1996;16:195-201.
22. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476.
23. Lin T-N, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24:117-121.
24. Wang Y. Chiou AL, Yang ST, Lin JC. Ketamine antagonizes hypoxiainduced dopamine release in rat striatum. Brain Res. 1995;693:233-245.
25. Stromberg I, Bjorklund L, Johansson M, Tomac A. Collins F, Olson L, Hoffer B, Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol. 1993;124:401-412.
26. Matheson CR, Carnahan J, Urich JL, Bocangel D, Zhang TJ, Yan Q. Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for sensory neurons: comparison with the effects of the neurotrophins. J Neurobiol. 1997;32:22-32.
27. 3, glial cell line-derived neurotrophic factor, and fibroblast growth factor-2, act in different manners to promote motoneuron survival in vitro. J Neurosci Res. 1996;43:454-464.
28. Zurn AD. Winkel L, Menoud A, Djabali K. Aebischer P. Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro. J Neurosci Res. 1996;44:133-141.
29. Lapchak PA, Jiao S, Collins F, Miller PJ. Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection. Brain Res. 1997;747:92-102.
30. Mabie PC. Mehler MF, Marmur R, Papavasiliou A. Song Q, Kessler JA. Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. J Neurosci. 1997;17:4112-4120.
31. Kretzschmar M, Liu F, Hata A. Doody J, Massague J. The TGF-beta family mediator Smadl is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 1997;11:984-995.
32. Kretzschmar M, Doody J, Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature. 1997;89:618-622.
33. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. Smad6 inhibits signalling by the TGF-β superfamily. Nature. 1997;389:622-631.
34. Lewen A, Soderstrom S, Hillered L, Ebendal T. Expression of serine/threonine kinase receptors in traumatic brain injury. Neuroreport. 1997; 8:475-479.
35. Basile DP, Rovak JM, Martin DR, Hammerman MR. Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol. 1996;270:F500-F509.
36. Knuckey NW, Finch P, Palm DE, Primiano MJ, Johanson CE, Flanders KC, Thompson NL. Differential neuronal and astroeytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. Brain Res Mol Brain Res. 1996;40:1-14.
37. Humpel C, Hoffer B, Stromberg I, Bektesh S, Collins F, Olson L. Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neumscience. 1994;59:791-795.
38. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993;260:1130-1132.
39. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 1995;373:339-341.
40. Trok K, Hoffer B, Olson L. Glial cell line-derived neurotrophic factor enhances survival and growth of prenatal and postnatal spinal cord transplants. Neuroscience. 1996;71:231-241.
41. Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 1996;382:73-76.
42. Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 1995;373:335-339.
43. Bowenkamp KE, Huffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffer BJ, Granholm AE. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol. 1995;355:479-489.
44. Lin SZ, Chiou AL. Wang Y. Ketamine antagonizes NO release from cerebral cortex after middle cerebral artery ligation. Stroke. 1996;27:747-752.
45. Abe K, Hayashi T, Itoyama Y. Amelioration of brain edema by topical application of glial cell line-derived neurotrophic factor in reperfused ral brain. Neurosci Lett. 1997;231:37-40.
46. Kawamata T, Ren JM. Chan TC, Charette M, Finklestein SP. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport. 1998;9:1441-1445.
47. LeRoux P, Behar S, Higgins D, Rueger D. OP-1 demonstrates support of dendritic growth from cerebral cortical neurons in vitro. Soc Neurosci Abstr. 1997;23:606. Abstract.
48. Lien P, Johnson M, Guo X, Rueger D, Higgins D. Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons. Neuron. 1995;15: 597-605.
49. Ogilvy C, Chu D, Kaplan S. Mild hypothermia, hypertension, and mannitol are protective against infarction during experimental intracranial temporary vessel occlusion. Neurosurgery. 1996;38:1202-1210.